An observational study in Choledochal Cyst Resection, sponsored by Wuhan Children's Hospital. Completed at 1 site in China. Open to participants aged 1 Week to 16 Years. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Wuhan Children's Hospital · Observational
This retrospective study aims to systematically analyze the factors influencing short-term rehabilitation and liver function recovery after radical surgery for pediatric common bile duct cysts, identify independent risk factors, construct a risk prediction model, and provide an evidence-based basis for optimizing perioperative management.
22 studies on the registry are indexed under Choledochal Cyst; 10 are open to participants now.
This study's enrollment of 550 is above the median of 400 across 14 observational studies indexed under Choledochal Cyst.
Browse Choledochal Cyst studies →Wuhan Children's Hospital is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
This study enrolled patients admitted between 2017 and 2025 to the Department of Hepatobiliary Surgery at Wuhan Children's Hospital, Anhui Provincial Children's Hospital, Shanxi Provincial Children's Hospital, Tianjin Children's Hospital, or the Affiliated Hospital of Zunyi Medical University. All patients were scheduled to receive either laparoscopic cholecystectomy and choledochal cyst excision, end-to-side jejunojejunal Y anastomosis and hepaticojejunostomy, or robot-assisted laparoscopic cholecystectomy and choledochal cyst excision, end-to-side jejunojejunal Y anastomosis and hepaticojejunostomy. The target population was patients aged 0-16 years who were definitively diagnosed with choledochal cyst via preoperative pathology or imaging examination, and met the indications for elective surgery. All enrolled patients must have complete perioperative clinical data, and be able to cooperate with postoperative follow-up observation until discharge.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
1) Age between 0-16 years, meeting the age-based classification criteria for pediatric patients; 2) Diagnosis of common bile duct cyst confirmed by imaging studies (liver and gallbladder ultrasonography, MRCP, or CT), with histological typing performed according to the Todani classification system; 3) First-time surgical resection of the common bile duct cyst combined with radical Roux-en-Y hepatojejunal anastomosis; 4) Complete clinical medical records, preoperative laboratory test data, intraoperative surgical documentation, postoperative rehabilitation and follow-up data; 5) The study cases are affiliated with respective participating research centers, and inpatient and follow-up data can be readily retrieved.
Exclusion Criteria:
1) Children with severe end-stage liver cirrhosis, irreversible liver failure, or malignant biliary tract tumors; 2) Children with severe multi-organ failure (e.g., cardiac, pulmonary, or renal failure) who cannot be adequately assessed for surgical prognosis; 3) Children undergoing secondary surgery or those with recurrent choledochal cysts; 4) Children who have only undergone palliative stoma creation or percutaneous drainage without receiving radical surgical intervention; 5) Cases in which critical perioperative clinical data are missing, making it impossible to meet the requirements for data analysis.
First flatus time (hours)
Time frame: From the date of surgery until the date of first flatus, assessed up to 7 days postoperatively.
First defecation time
Time frame: From the date of surgery until the date of first defecation, assessed up to 7 days postoperatively.
Postoperative length of hospital stay (days)
Time frame: From the date of surgery until the date of hospital discharge, assessed up to 3 months postoperatively.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wuhan Children's Hospital